EU POLICY ON ORPHAN DRUGS

被引：1
|
作者：
LEWIS, S
机构：
来源：
LANCET | 1995年 / 345卷 / 8963期
关键词：
D O I：
10.1016/S0140-6736(95)91053-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1500 / 1500
页数：1
相关论文
共 50 条
  • [1] EU TO DISCUSS BRIEF ON ORPHAN DRUGS POLICY
    不详
    EUROPEAN CHEMICAL NEWS, 1995, 63 (1667): : 4 - 4
  • [2] Orphan drugs EU regulations
    Mariz, Segundo
    Llinares, Jordi
    Westermark, Kerstin
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [3] Orphan drugs: Review of the EU program
    Del Signore, S.
    EPILEPSIA, 2006, 47 : 238 - 238
  • [4] EU to provide incentives for "orphan" drugs
    Watson, R
    BRITISH MEDICAL JOURNAL, 2000, 320 (7245): : 1294 - 1294
  • [5] ORPHAN DRUGS - CREATING A POLICY
    ASBURY, CH
    STOLLEY, PD
    ANNALS OF INTERNAL MEDICINE, 1981, 95 (02) : 221 - 224
  • [6] Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU
    Joppi, Roberta
    Bertele', Vittorio
    Garattini, Silvio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 1009 - 1024
  • [7] Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU
    Roberta Joppi
    Vittorio Bertele’
    Silvio Garattini
    European Journal of Clinical Pharmacology, 2013, 69 : 1009 - 1024
  • [8] EU 'could do better' on orphan drugs
    Rice, Mary
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (10) : 1319 - 1319
  • [9] TIME FOR A EUROPEAN ORPHAN DRUGS POLICY
    LEBLOND, D
    EUROPEAN CHEMICAL NEWS, 1995, 63 (1652): : 17 - 17
  • [10] TIME FOR REIMBURSEMENT FOR ORPHAN DRUGS IN EU5
    Prada, M.
    Berard, I
    Walzer, S.
    Darba, J.
    Greenwood, B.
    VALUE IN HEALTH, 2018, 21 : S264 - S264
12345